A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects

NCT05031624 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: CDX-0159
DRUG: Normal saline

Sponsor

Celldex Therapeutics